Acute kidney injury: Difference between revisions
From IDWiki
(ββ) |
(ββ: linkified) |
||
Line 26: | Line 26: | ||
*Pre-renal: decreased renal perfusion |
*Pre-renal: decreased renal perfusion |
||
**Hypovolemia |
**[[Hypovolemia]] |
||
**Blood loss |
**[[Blood loss]] |
||
**Shock |
**[[Shock]] |
||
**Sepsis |
**[[Sepsis]] |
||
**Heart failure |
**[[Heart failure]] |
||
**Vomiting and diarrhea |
**[[Vomiting]] and [[diarrhea]] |
||
*Renal/intrinsic |
*Renal/intrinsic |
||
**Glomerulonephritis (GN): glomerular damage |
**[[Glomerulonephritis]] (GN): glomerular damage |
||
***Primary |
***Primary |
||
****Minimal change (in children) |
****Minimal change (in children) |
||
Line 40: | Line 40: | ||
***Secondary |
***Secondary |
||
****Focal sclerosing or diffuse (in diabetic patients) |
****Focal sclerosing or diffuse (in diabetic patients) |
||
****Lupus, multiple myeloma, and amyloidosis |
****[[Lupus]], [[multiple myeloma]], and [[amyloidosis]] |
||
**Acute tubular necrosis (ATN): tubular damage |
**[[Acute tubular necrosis]] (ATN): tubular damage |
||
***Ischemia from prerenal disease |
***[[Ischemia]] from prerenal disease |
||
***Toxins |
***Toxins |
||
***Drugs |
***Drugs |
||
****Aminoglycosides |
****[[Aminoglycosides]] |
||
****Amphotericin |
****[[Amphotericin B|Amphotericin]] |
||
****Cisplatin |
****[[Cisplatin]] |
||
***Pigments: hemoglobin, myoglobin |
***Pigments: hemoglobin, myoglobin |
||
***Proteins: immunoglobulin light chains (e.g. multiple myeloma) |
***Proteins: immunoglobulin light chains (e.g. [[multiple myeloma]]) |
||
***Crystals |
***Crystals |
||
****Uric acid |
****[[Gout|Uric acid]] |
||
****Acyclovir |
****[[Acyclovir]] |
||
****Methotrexate |
****[[Methotrexate]] |
||
****Indinavir |
****[[Indinavir]] |
||
****Oral |
****Oral sodium phosphate |
||
***Contrast-induced |
***Contrast-induced |
||
**Acute interstitial nephritis (AIN): interstitial damage |
**[[Acute interstitial nephritis]] (AIN): interstitial damage |
||
***Allergic |
***Allergic |
||
****Antibiotics: beta-lactams, |
****Antibiotics: [[Ξ-lactams|beta-lactams]], [[sulfonamides]] |
||
**** |
****[[NSAID]] |
||
**** |
****[[PPI]] |
||
***Infective |
***Infective |
||
****Pyelonephritis |
****[[Pyelonephritis]] |
||
****Legionellosis |
****[[Legionellosis]] |
||
***Infiltration |
***Infiltration |
||
****Sarcoidosis |
****[[Sarcoidosis]] |
||
****Lymphoma |
****[[Lymphoma]] |
||
****Leukemia |
****[[Leukemia]] |
||
***Autoimmune |
***Autoimmune |
||
****SjΓΆgren |
****[[SjΓΆgren syndrome]] |
||
****TINU syndrome |
****[[TINU syndrome]] |
||
****IgG4 disease |
****[[IgG4 disease]] |
||
****Systemic lupus |
****[[Systemic lupus erythematosus]] |
||
***Small vessel disease |
***Small vessel disease |
||
****Cholesterol emboli |
****Cholesterol emboli |
||
****Thrombotic microangiopathy |
****[[Thrombotic microangiopathy]] |
||
*****HUS/TTP |
*****[[HUS]]/[[TTP]] |
||
*****DIC |
*****[[DIC]] |
||
*****Preeclampsia |
*****[[Preeclampsia]] |
||
*****Anti-phospholipid syndrome (APS) |
*****[[Anti-phospholipid syndrome]] (APS) |
||
*****Malignant hypertension |
*****[[Malignant hypertension]] |
||
*****Scleroderma renal crisis |
*****[[Scleroderma renal crisis]] |
||
*Post-renal (obstructive) |
*Post-renal (obstructive) |
||
**Bladder neck |
**Bladder neck |
||
***BPH or prostate cancer (in men) |
***[[BPH]] or [[prostate cancer]] (in men) |
||
***Cervical cancer (in women) |
***[[Cervical cancer]] (in women) |
||
**Neurogenic bladder |
**[[Neurogenic bladder]] |
||
***Anticholinergics |
***[[Anticholinergics]] |
||
**Ureteral (bilateral) |
**Ureteral (bilateral) |
||
***Malignancy |
***[[Malignancy]] |
||
***[[Lymphadenopathy]] |
|||
***LAN |
|||
***Retroperitoneal fibrosis |
***[[Retroperitoneal fibrosis]] |
||
***Nephrolithiasis |
***[[Nephrolithiasis]] |
||
==Clinical Manifestations== |
==Clinical Manifestations== |
Revision as of 21:23, 10 August 2020
Definition
- An inability of the kidneys to maintain body homeostasis, usually defined by an acute increase in creatinine
AKIN Stage
Stage | Serum creatinine | Or, urine output |
---|---|---|
1 | Creatinine increase β₯26.5 umol/L or 1.5-2 times baseline | <0.5ml/kg/h for 6h |
2 | Creatinine increase 2-3 times baseline | <0.5ml/kg/h for 12h |
3 | Creatinine increase >3 times baseline, or creatinine β₯354 umol/L increased by at least 44 umol/L, or need for dialysis | <0.3ml/kg/h for 24h |
Differential Diagnosis
- Pre-renal: decreased renal perfusion
- Renal/intrinsic
- Glomerulonephritis (GN): glomerular damage
- Primary
- Minimal change (in children)
- Membranous (in adults)
- Focal sclerosing (in HIV patients)
- Secondary
- Focal sclerosing or diffuse (in diabetic patients)
- Lupus, multiple myeloma, and amyloidosis
- Primary
- Acute tubular necrosis (ATN): tubular damage
- Ischemia from prerenal disease
- Toxins
- Drugs
- Pigments: hemoglobin, myoglobin
- Proteins: immunoglobulin light chains (e.g. multiple myeloma)
- Crystals
- Uric acid
- Acyclovir
- Methotrexate
- Indinavir
- Oral sodium phosphate
- Contrast-induced
- Acute interstitial nephritis (AIN): interstitial damage
- Allergic
- Antibiotics: beta-lactams, sulfonamides
- NSAID
- PPI
- Infective
- Infiltration
- Autoimmune
- Small vessel disease
- Cholesterol emboli
- Thrombotic microangiopathy
- Allergic
- Glomerulonephritis (GN): glomerular damage
- Post-renal (obstructive)
- Bladder neck
- BPH or prostate cancer (in men)
- Cervical cancer (in women)
- Neurogenic bladder
- Ureteral (bilateral)
- Bladder neck
Clinical Manifestations
Clinical clues of etiology
Type | History | Examination |
---|---|---|
Prerenal | Volume loss (e.g. vomiting, diarrhea, diuretics, hemorrhage, burns) Thirst and reduced fluid intake Heart failure or cirrhosis |
Weight loss, orthostatic hypotension and tachycardiac, poor skin turgor, signs of heart failure or liver failure |
Intrinsic renal | ||
ATN | History of nephrotoxic medications, hypotension, trauma or myalgias suggestion rhabdo, CT contrast | Muscle tenderness, compartment syndrome, volume status |
GN | Lupus, systemic sclerosis, rash, arthritis, uveitis, weight loss, fatigue, HCV infection, HIV infection, hematuria, foamy urine, cough, sinusitis, hemoptysis | Periorbital, sacral, and lower-extremity edema; rash; oral or nasal ulcers |
AIN | Medication use (antiiotics, PPIs), rash, arthralgias, fever, infection | Fever, drug rash |
Vascular | Nephrotic syndrome, trauma, flank pain, anticoagulation, vascular surgery | Livedo reticularis, fundoscopy showing malignant hypertension, abdominal bruits |
Post-renal | Urinary urgency or hesitancy, gross hematuria, polyuria, stones, medications, cancer | Bladder distension, pelvic mass, prostate enlargement |
Source: Rahman M, Shad F, and Smith MC. Acute kidney injury: A guide to diagnosis and management. Am Fam Physician. 2012;86(7):631-639.
Investigations
- Laboratory
- Urinalysis and microscopy
- Granular casts (from heme), suggesting ATN
- Red blood cell casts, suggesting GN
- Urine sodium
- <10mmol/L suggests pre-renal, unless diuresed
- Urea to creatinine ratio
- Increased ratio suggests pre-renal cause
- Extended electrolytes
- Urinalysis and microscopy
- Renal ultrasound, for possible obstruction
Fractional excretion of sodium (FENa)
$FENa = \frac{U_{Na} \div U_{Cr}}{S_{Na} \div S_{Cr}} = \frac{U_{Na} \times S_{Cr}}{S_{Na} \times U_{Cr}}$
FENa | Etiology |
---|---|
<1% | Pre-renal |
1 to 4% >2% |
Intrinsic renal Acute tubular necrosis (ATN) |
>4% | Post-obstructive |
Management
- Treatment depends on etiology
- Prerenal: Fluid challenge
- Renal: Stop nephrotoxic medications
- Post-renal: Nephrostomy tubes
- Dialysis if
- Acidosis
- Electrolyte imbalance (K+)
- Intoxication (drugs, alcohols)
- Overloaded fluid (heart failure)
- Uremia (pericarditis, neurological symptoms)
Prognosis
- Increased risk of developing CKD with
- Increasing age
- Female sex
- AKIN stage
- Absolute increase in serum creatinine
- Albuminuria